- BiondVax Pharmaceuticals Ltd. (BVXV): Important & Key Factors of Healthcare Stock
- What's the Analyst Recommendation for iHeartMedia Inc. (IHRT)?
- Let’s Take a Look at Milestone Pharmaceuticals Inc. (MIST) Stock
- Is it Time to Sell/Buy United States Steel Corporation (X) Stock After Recent Trade?
- Aptose Biosciences Inc. (APTO) is down -10.05% this year
Five Prime Therapeutics Inc. (FPRX) share price soared 5.08% with the closing price of $5.38 on Friday. Five Prime Therapeutics Inc. stock has an exchanging volume of 1.03 million shares, which is high, contrasted with its 3-months average volume of 317.76K shares. Its market capitalization has now reached to $187.49M and analysts have a consensus target price of $8.83 in the 12-month period.
Guggenheim announced it was Upgrade coverage of Five Prime Therapeutics Inc. in a research note on September 22, 2020. Wedbush rated the stock as an Outperform in a research noted published on June 22, 2020. JP Morgan rated the stock as an Underweight in a research note published on February 28, 2020.
Five Prime Therapeutics to Participate in the 2020 Wells Fargo Virtual Healthcare Conference on September 9, 2020 news published at Yahoo.
FPRX Past Trading Activity
The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, FPRX price has rose by 10.70%. In the course of past three months sees the stock go down around -8.66%, while it has gain 97.79% over the past six months and 17.21% since the start of the year.
FPRX Earning History
Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Sep 2020), the firm recorded a revenue of 3.42 billion, which was higher than the gauge of 3.41M made by certain experts. For that equivalent quarter, Five Prime Therapeutics Inc. posted -$0.48 earnings per share (EPS) which was above the consensus estimate of -$0.69 by $0.21, which represents to an expansion by 30.40%.
FPRX Price Performance
Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Five Prime Therapeutics Inc. has seen its stock exchanging -26.70% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +48.01% above its three-month low. A more extensive look sees FPRX exchanging -26.70% beneath its 52-week high and 207.43% above from its 52-week low price.
FPRX Instability & Beta Factor
The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 10.82%, while it has a month to month instability of 8.91%. The company has an ATR (Average True Range) of 0.41 and a beta factor of 1.91.